Citeline Alternative: Clinical Trial Monitoring Without the Sales Call
Citeline and Evaluate Pharma are intelligence platforms for pharma: neither publishes a price, and both route you to a demo or a specialist. DataLookout covers the ClinicalTrials.gov monitoring layer for $49/month, with no contract and a 2-minute setup.
Citeline does not publish a price. DataLookout starts at $0.
Daily change tracking, a free tier to start, and no procurement process.
Who actually looks for a Citeline alternative?
- Someone at a clinical-stage biotech described the usual setup as the BD team catching things by hand, Google Alerts, or a patchwork of ClinicalTrials.gov RSS feeds with an intern checking them, and said the registry's volume of weekly amendments makes the real problem signal-to-noise. A reply from the big-pharma side named Citeline TrialTrove as what CI teams use instead. (r/biopharma thread, March 2026)
- An independent consultant wanted a single-user, cost-effective tool to scan pipelines, saying most offerings run to tens of thousands of dollars. (r/biotech thread, October 2024)
- A Citeline power user called it clunky but very useful. Our summary: the enterprise platforms are good, and they are priced and sold for enterprises. (r/biotech thread, November 2023)
DataLookout is the ClinicalTrials.gov change layer for the first two: one seat, $49/month for Pro, a free tier to start, and the diff done for you instead of by the intern. It does not carry Citeline's enriched multi-source data.
Citeline and Evaluate Pharma vs DataLookout
| Feature | Citeline | Evaluate Pharma | DataLookout |
|---|---|---|---|
| Clinical trial data | Yes: Trialtrove, analyst-curated | Not mentioned on the product page | Yes: ClinicalTrials.gov, daily scan |
| Change alerts by email | Not mentioned | Not mentioned | Built-in, default |
| Data source | Analyst-curated; Trialtrove cites 60,000+ sources (its figure) | Consensus forecasts, sales data, deals | ClinicalTrials.gov |
| Setup | Demo or specialist request | Demo or specialist request | 2 minutes |
| Contract | Not stated on the product page | Not stated on the product page | No: monthly or yearly, cancel anytime |
| Starting price | Not published | Not published | Free, then $49/month |
What do Citeline and Evaluate Pharma offer?
Citeline (a Norstella company) and Evaluate Pharma are intelligence platforms for pharma. Their product pages (checked August 22, 2026) describe:
- Citeline: analyst-curated clinical products (Trialtrove, Sitetrove, Pharmaprojects); Trialtrove cites 60,000+ sources (its figure)
- Evaluate Pharma: consensus sales forecasts for almost 6,000 drugs, historic sales data, deal monitoring, development and regulatory timelines, patent-expiry dates (its figures)
- Both: sold through a demo or a specialist, no published price, no free tier mentioned
Neither publishes a price.
What gap do the enterprise platforms leave?
Neither platform publishes a price, and both route you to a sales conversation before you can start. That leaves a gap for:
- Small and mid-size biotechs that want a seat without a procurement process
- Individual BD professionals who want monitoring on a personal budget
- Academic medical centers tracking clinical programs in their disease areas
- Investors who want trial status monitoring without a full enterprise intelligence subscription
- Teams that need the ClinicalTrials.gov monitoring layer and not the financial data or analyst forecasts
DataLookout is built for this gap. We don't try to replicate everything Citeline does. We do one thing well: monitor ClinicalTrials.gov daily and tell you what's new in the areas you care about.
How does DataLookout handle the monitoring layer?
Daily scan of ClinicalTrials.gov
Every day, DataLookout takes a fresh snapshot of the ClinicalTrials.gov records it monitors and compares each one to the previous day's version. The diff engine tracks 13 fields, including overall status, enrollment, primary endpoints, interventions, results posting, site counts, and completion dates, and marks every change Stopped, Notable or Minor.
Watchlists and saved searches
You choose what to monitor: watch a sponsor, watch a disease area, or save a search with the filters you care about. The free plan includes 1 sponsor + 1 disease watchlist and 1 saved search, free forever. Pro raises the limits to 10 of each.
Email digest and dashboard inbox
Changes reach you two ways: a morning email digest for your watchlists, and an inbox in the dashboard where you can review each change and mark it seen or done. Every change links to the trial's detail page, which shows the change history and links back to the ClinicalTrials.gov record.
Which tool fits which job?
DataLookout, if:
You primarily need to monitor ClinicalTrials.gov for competitive intelligence and don't need financial forecasts or deal databases. You're a small/mid biotech, individual BD professional, or investor who wants public pricing. You want a daily digest that arrives in your inbox without logging into another platform.
Citeline or Evaluate Pharma, if:
You need consensus sales forecasts, deal data, or analyst-curated trial and site intelligence in one platform.
Frequently asked questions
Related resources
Try DataLookout free
1 sponsor + 1 disease watchlist with daily change detection. Free forever, no credit card.
Get started freeDataLookout checks ClinicalTrials.gov every day and records what changed on each trial: status, enrollment, phase, primary endpoint, completion dates, sites, sponsor, and the stated reason a trial stopped. Add a sponsor or a disease to your watchlist, or save any search, and the changes arrive in a daily or weekly email digest.
Free, $0 forever: 1 sponsor + 1 disease watchlist, 1 saved search in your email digest, track up to 5 individual trials, daily change detection, Trials at Risk (top 2 trials), the weekly report (top 3 trials). No credit card.
Pro, $49/month or $490/year: 10 sponsor + 10 disease watchlists, 10 saved searches in your email digest, track up to 25 individual trials, full Trials at Risk list, Completions calendar, the full weekly report, landscape reports, CSV export.